[HTML][HTML] A computational approach to design potential siRNA molecules as a prospective tool for silencing nucleocapsid phosphoprotein and surface glycoprotein …

UF Chowdhury, MUS Shohan, KI Hoque, MA Beg… - Genomics, 2021 - Elsevier
An outbreak, caused by an RNA virus, SARS-CoV-2 named COVID-19 has become
pandemic with a magnitude which is daunting to all public health institutions in the absence …

[HTML][HTML] Design of siRNA molecules for silencing of membrane glycoprotein, nucleocapsid phosphoprotein, and surface glycoprotein genes of SARS-CoV2

VS Ayyagari - Journal of Genetic Engineering and Biotechnology, 2022 - Elsevier
The global COVID-19 pandemic caused by SARS-CoV2 infected millions of people and
resulted in more than 4 million deaths worldwide. Apart from vaccines and drugs, RNA …

In silico prediction of siRNA to silence the SARS-CoV-2 omicron variant targeting BA. 4, BA. 5, BQ. 1, BQ1. 1. and XBB: an alternative to traditional therapeutics

R Islam, A Shahriar, N Fatema, MR Uddin… - Future Journal of …, 2023 - Springer
Background After the first infection in December 2019, the mutating strains of SARS-CoV2
have already affected a lot of healthy people around the world. But situations have not been …

Immunoinformatic and molecular docking approaches: siRNA prediction to silence cell surface binding protein of monkeypox virus

R Islam, A Shahriar, MR Uddin, N Fatema - Beni-Suef University Journal of …, 2024 - Springer
Background Monkeypox virus (MPV), an endemic pathogen in Africa, shares clinical
similarities with smallpox. Recent reports indicate a concerning increase in the number of …

Exploring the potential of structural modeling and molecular docking for efficient siRNA screening: A promising approach to Combat viral mutants, with a focus on HIV …

M Nematian, Z Noormohammadi, P Rahimi… - Biochemical and …, 2024 - Elsevier
RNA interference (RNAi) holds immense potential for sequence-specific downregulation of
disease-related genes. Small interfering RNA (siRNA) therapy has made remarkable strides …

In vitro inhibition of replication of dengue virus serotypes 1–4 by siRNAs bound to non-toxic liposomes

CA Rodriguez-Salazar, DP Recalde-Reyes, JP Bedoya… - Viruses, 2022 - mdpi.com
Dengue virus is a ssRNA+ flavivirus, which produces the dengue disease in humans.
Currently, no specific treatment exists. siRNAs regulate gene expression and have been …

Strategic Design of Dicer Substrate siRNA to Mitigate the Resistance Mediated by ABCC1 in Doxorubicinresistant Breast Cancer.

AK Gatta, R Chandrashekhar… - Indian Journal of …, 2020 - search.ebscohost.com
The current study involved designing of a small interfering ribonucleic acid-loaded folate
functionalized chitosan-coated PLGA nanoparticles to evaluate tumor targeting potential in …

Subtractive proteomics approach to Unravel the druggable proteins of the emerging pathogen Waddlia chondrophila and drug repositioning on its MurB protein

UF Chowdhury, A Al Saba, AS Sufi, AM Khan… - Heliyon, 2021 - cell.com
Waddlia chondrophila is an emerging pathogen that has been implicated in numerous
unpropitious pregnancy events in humans and ruminants. Taking into account its …

SiRNA Molecules as Potential RNAi Therapeutics to Silence RdRP Region and N-Gene of SARS-CoV-2: An In Silico Approach

M Hasan, AT Tasnim, AI Ashik, MB Chowdhury… - bioRxiv, 2022 - biorxiv.org
COVID-19 pandemic keeps pressing onward and effective treatment option against it is still
far-off. Since the onslaught in 2020, 13 different variants of SARS-CoV-2 have been …

[HTML][HTML] Computational design of potential siRNA molecules for silencing of protease (3LC-like proteinase) and RNA-dependent RNA polymerase gene of SARS-CoV …

MA Karim, T Sarker, A Samad, F Ahammad, J Jaman… - 2022 - europepmc.org
Since the origin of the SARS-CoV2 from Wuhan, in China, it has become a global threat to
public health and a WHO-declared world epidemic within 2 month of identification of the first …